BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18366965)

  • 1. Reversible posterior leukoencephalopathy syndrome in cancer.
    Vaughn C; Zhang L; Schiff D
    Curr Oncol Rep; 2008 Jan; 10(1):86-91. PubMed ID: 18366965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Posterior Reversible Encephalopathy Syndrome Associated with Cancer Therapy].
    Mitsuya K; Nakasu Y; Hayashi N; Yasui H; Ikeda T; Kuji S; Onozawa Y; Endo M
    No Shinkei Geka; 2016 Mar; 44(3):211-9. PubMed ID: 26965062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible posterior leukoencephalopathy syndrome.
    Moon JM; Chun BJ
    J Emerg Med; 2010 Apr; 38(3):e1-4. PubMed ID: 18024064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversible posterior leukoencephalopathy syndrome (RPLS) associated with Wegener's granulomatosis: a case report and review of the literature].
    Onozawa R; Tsuboi Y; Obata T; Inoue H; Yamada T; Miyake K
    Rinsho Shinkeigaku; 2012; 52(8):567-70. PubMed ID: 22975855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer.
    Wang W; Zhao LR; Lin XQ; Feng F
    World J Gastroenterol; 2014 Jun; 20(21):6691-7. PubMed ID: 24914397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible posterior leukoencephalopathy syndrome due to adrenal pheochromocytoma: A case report and literature review.
    Han B; Li Y; Tang M; Wu S; Xu X
    Medicine (Baltimore); 2020 Jul; 99(28):e20918. PubMed ID: 32664087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.
    Chang Y; Mbeo G; Littman SJ
    J Gastrointest Cancer; 2012 Sep; 43(3):505-7. PubMed ID: 21556724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of blood pressure on reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia.
    Xiaobo F; Yanling L; Dunjin C; Fang H; Jia C; Yuhua Z; Weixi Z
    Hypertens Res; 2018 Feb; 41(2):112-117. PubMed ID: 29093565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on clinicoradiological characteristics and pregnancy outcomes of reversible posterior leukoencephalopathy syndrome in preeclampsia or eclampsia.
    Fang X; Liang Y; Chen D; He F; Chen J; Huang F
    Hypertens Res; 2017 Dec; 40(12):982-987. PubMed ID: 28878299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature.
    Gümüş H; Per H; Kumandaş S; Yikilmaz A
    Neurol Sci; 2010 Apr; 31(2):125-31. PubMed ID: 19809787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible posterior leukoencephalopathy induced by carboplatin and etoposide.
    Ryan SA; Maceneaney P; O'Reilly SP; Moylan EJ; Power DG
    Med Oncol; 2012 Jun; 29(2):1287-91. PubMed ID: 21390516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?
    Shah RR
    Drug Saf; 2017 May; 40(5):373-386. PubMed ID: 28181126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible posterior leukoencephalopathy syndrome caused by blood transfusion: a case report.
    Huang YC; Tsai PL; Yeh JH; Chen WH
    Acta Neurol Taiwan; 2008 Dec; 17(4):258-62. PubMed ID: 19280871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible posterior leukoencephalopathy syndrome: a possible manifestation of Wegener's granulomatosis-mediated endothelial injury.
    Nishio M; Yoshioka K; Yamagami K; Morikawa T; Konishi Y; Hayashi N; Himuro K; Imanishi M
    Mod Rheumatol; 2008; 18(3):309-14. PubMed ID: 18415039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible posterior leukoencephalopathy syndrome: a case presentation.
    Bell AJ
    Neurodiagn J; 2012 Mar; 52(1):20-33. PubMed ID: 22558644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible posterior leukoencephalopathy syndrome after carboplatin and paclitaxel regimen for lung cancer.
    Imai H; Okuno N; Ishihara S; Nakano S; Higuchi S; Arai T; Tokunaga M; Kobayashi H; Arai T; Mori M
    Intern Med; 2012; 51(8):911-5. PubMed ID: 22504249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features of preeclampsia-eclampsia patients with reversible posterior leukoencephalopathy syndrome].
    Lu HY; Xie BD; Cheng Y; Niu XM
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(3):178-81. PubMed ID: 20356553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on clinical characteristics and the causes of missed diagnosis of reversible posterior leukoencephalopathy syndrome in eclampsia.
    Shen T; Chen H; Jing J; Raza HK; Zhang Z; Bao L; Zhou S; Zhang S; Cui G
    Neurol Sci; 2019 Sep; 40(9):1873-1876. PubMed ID: 31062190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversible posterior leukoencephalopathy syndrome in a patient presenting granulomatosis with polyangiitis].
    Chaput L; Rabot N; Limousin N; Cottier JP; Lioger B; Samimi M
    Ann Dermatol Venereol; 2017 Feb; 144(2):113-120. PubMed ID: 27502754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior reversible encephalopathy syndrome: a neurologic phenomenon in cancer patients.
    Le EM; Loghin ME
    Curr Oncol Rep; 2014 May; 16(5):383. PubMed ID: 24595679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.